A Comprehensive High Resolution Scrna-Seq Analytical Platform for Characterizing Human Hematopoietic Stem/Progenitor Cells States in Ex Vivo Drug Products
Cristina Baricordi(Broad Institute), Luca Biasco(Institute of Infection and Immunity), Mariana Loperfido(ProterixBio (United States)), Azadeh Golipour(ProterixBio (United States)), Aimin Yan(ProterixBio (United States)), Mercèdes Segura(ProterixBio (United States)), Chris Mason(Oak Ridge National Laboratory), Luigi Barbarossa(ProterixBio (United States))
Cited by 0
Related Papers
A Brief Definition of Regenerative Medicine
|Regenerative Medicine|2007|795
Highly efficient therapeutic gene editing of human hematopoietic stem cells
|Nature Medicine|2019|518
BTRFS
|ACM Transactions on Storage|2013|381
Lancet Commission: Stem cells and regenerative medicine
|The Lancet|2017|276
Cell Therapy Industry: Billion Dollar Global Business with Unlimited Potential
|Regenerative Medicine|2011|144